Transgenic models of Huntington's disease

被引:49
作者
Sathasivam, K
Hobbs, C
Mangiarini, L
Mahal, A
Turmaine, M
Doherty, P
Davies, SW
Bates, GP
机构
[1] Kings Coll London, GKT Med & Dent Sch, Guys Hosp, London SE1 9RT, England
[2] Kings Coll London, Guys Hosp, GKT Med & Dent Sch, London SE1 9RT, England
[3] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England
基金
英国惠康基金;
关键词
Huntington's disease; polyglutamine repeat; transgenic mouse; neurodegeneration; amyloid;
D O I
10.1098/rstb.1999.0447
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
1Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a CAG-polyglutamine repeat expansion. A mouse model of this disease has been generated by the introduction of exon 1 of the human HD gene carrying highly expanded CAG repeats into the mouse germ line (R6 lines). Transgenic mice develop a progressive neurological phenotype with a movement disorder and weight loss similar to that in HD. We have previously identified neuronal inclusions in the brains of these mice that have subsequently been established as the pathological hallmark of polyglutamine disease. Inclusions are present before symptoms, which in turn occur long before any selective neuronal cell death can be identified. We have extended the search for inclusions to skeletal muscle, which, like brain, contains terminally differentiated cells. We have conducted an investigation into the skeletal muscle atrophy that occurs in the R6 lines, (i) to provide possible insights into the muscle bulk loss observed in HD patients, and (ii) to conduct a parallel analysis into the consequence of inclusion formation to that being performed in brain. The identification of inclusions in skeletal muscle might be additionally useful in monitoring the ability of drugs to prevent inclusion formation in vivo.
引用
收藏
页码:963 / 969
页数:7
相关论文
共 36 条
[1]   STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT [J].
AMBROSE, CM ;
DUYAO, MP ;
BARNES, G ;
BATES, GP ;
LIN, CS ;
SRINIDHI, J ;
BAXENDALE, S ;
HUMMERICH, H ;
LEHRACH, H ;
ALTHERR, M ;
WASMUTH, J ;
BUCKLER, A ;
CHURCH, D ;
HOUSMAN, D ;
BERKS, M ;
MICKLEM, G ;
DURBIN, R ;
DODGE, A ;
READ, A ;
GUSELLA, J ;
MACDONALD, ME .
SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) :27-38
[2]  
[Anonymous], HDB SCIENCE
[3]   Transgenic mice in the study of polyglutamine repeat expansion diseases [J].
Bates, GP ;
Mangiarini, L ;
Davies, SW .
BRAIN PATHOLOGY, 1998, 8 (04) :699-714
[4]   COMPARATIVE SEQUENCE-ANALYSIS OF THE HUMAN AND PUFFERFISH HUNTINGTONS-DISEASE GENES [J].
BAXENDALE, S ;
ABDULLA, S ;
ELGAR, G ;
BUCK, D ;
BERKS, M ;
MICKLEM, G ;
DURBIN, R ;
BATES, G ;
BRENNER, S ;
BECK, S ;
LEHRACH, H .
NATURE GENETICS, 1995, 10 (01) :67-76
[5]   Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length [J].
Becher, MW ;
Kotzuk, JA ;
Sharp, AH ;
Davies, SW ;
Bates, GP ;
Price, DL ;
Ross, CA .
NEUROBIOLOGY OF DISEASE, 1998, 4 (06) :387-397
[6]  
CARTER RJ, 1999, IN PRESS J NEUROSCI
[7]   Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene [J].
Cha, JHJ ;
Kosinski, CM ;
Kerner, JA ;
Alsdorf, SA ;
Mangiarini, L ;
Davies, SW ;
Penney, JB ;
Bates, GP ;
Young, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6480-6485
[8]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[9]   MORPHOMETRIC DEMONSTRATION OF ATROPHIC CHANGES IN THE CEREBRAL-CORTEX, WHITE MATTER, AND NEOSTRIATUM IN HUNTINGTONS-DISEASE [J].
DELAMONTE, SM ;
VONSATTEL, JP ;
RICHARDSON, EP .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (05) :516-525
[10]   Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation [J].
DeRooij, KE ;
Dorsman, JC ;
Smoor, MA ;
DenDunnen, JT ;
VanOmmen, GJB .
HUMAN MOLECULAR GENETICS, 1996, 5 (08) :1093-1099